How much profit has Catalent made this year?
Catalent has made 36.69 M USD this year.
Catalent Net Income 2024
Catalent Net Income
36.69 M USD
Ticker
CTLT
ISIN
US1488061029
WKN
A112H2
In 2024, Catalent's profit amounted to 36.69 M USD, a -114.33% increase from the -256 M USD profit recorded in the previous year.
The Catalent Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2030e | 875 |
| 2029e | 708.86 |
| 2028e | 563.03 |
| 2027e | 439.35 |
| 2026e | 325.79 |
| 2025e | 207.82 |
| 2024e | 36.69 |
| 2023 | -256 |
| 2022 | 483 |
| 2021 | 529 |
| 2020 | 173 |
| 2019 | 137.4 |
| 2018 | 83.6 |
| 2017 | 109.8 |
| 2016 | 111.5 |
| 2015 | 212.2 |
| 2014 | 16.2 |
| 2013 | -49.6 |
| 2012 | -24.4 |
| 2011 | -54 |
| 2010 | -289.6 |
| 2009 | -308.1 |
Catalent Revenue, EBIT, Net Income US1488061029 · A112H2
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Catalent, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Catalent from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Catalent’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Catalent. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Catalent’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Catalent’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Catalent’s growth potential.
Catalent Revenue, EBIT and net profit per share
| Date | Catalent Revenue | Catalent EBIT | Catalent Net Income |
|---|---|---|---|
| 2030e | 7.1 B undefined | 0 undefined | 875 M undefined |
| 2029e | 6.5 B undefined | 0 undefined | 708.86 M undefined |
| 2028e | 5.97 B undefined | 1.2 B undefined | 563.03 M undefined |
| 2027e | 5.5 B undefined | 1.02 B undefined | 439.35 M undefined |
| 2026e | 4.99 B undefined | 617.66 M undefined | 325.79 M undefined |
| 2025e | 4.67 B undefined | 492.37 M undefined | 207.82 M undefined |
| 2024e | 4.4 B undefined | 276.81 M undefined | 36.69 M undefined |
| 2023 | 4.26 B undefined | 113 M undefined | -256 M undefined |
| 2022 | 4.8 B undefined | 729 M undefined | 483 M undefined |
| 2021 | 4 B undefined | 646 M undefined | 529 M undefined |
| 2020 | 3.09 B undefined | 405.4 M undefined | 173 M undefined |
| 2019 | 2.52 B undefined | 293.1 M undefined | 137.4 M undefined |
| 2018 | 2.46 B undefined | 290 M undefined | 83.6 M undefined |
| 2017 | 2.08 B undefined | 252 M undefined | 109.8 M undefined |
| 2016 | 1.85 B undefined | 229.5 M undefined | 111.5 M undefined |
| 2015 | 1.83 B undefined | 278 M undefined | 212.2 M undefined |
| 2014 | 1.83 B undefined | 263.8 M undefined | 16.2 M undefined |
| 2013 | 1.8 B undefined | 228 M undefined | -49.6 M undefined |
| 2012 | 1.69 B undefined | 210.5 M undefined | -24.4 M undefined |
| 2011 | 1.53 B undefined | 213.8 M undefined | -54 M undefined |
| 2010 | 1.48 B undefined | 170.8 M undefined | -289.6 M undefined |
| 2009 | 1.4 B undefined | 139.3 M undefined | -308.1 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2009 | 1.4 B USD | 139.3 M USD | -308.1 M USD |
| 2010 | 1.48 B USD | 170.8 M USD | -289.6 M USD |
| 2011 | 1.53 B USD | 213.8 M USD | -54 M USD |
| 2012 | 1.69 B USD | 210.5 M USD | -24.4 M USD |
| 2013 | 1.8 B USD | 228 M USD | -49.6 M USD |
| 2014 | 1.83 B USD | 263.8 M USD | 16.2 M USD |
| 2015 | 1.83 B USD | 278 M USD | 212.2 M USD |
| 2016 | 1.85 B USD | 229.5 M USD | 111.5 M USD |
| 2017 | 2.08 B USD | 252 M USD | 109.8 M USD |
| 2018 | 2.46 B USD | 290 M USD | 83.6 M USD |
| 2019 | 2.52 B USD | 293.1 M USD | 137.4 M USD |
| 2020 | 3.09 B USD | 405.4 M USD | 173 M USD |
| 2021 | 4 B USD | 646 M USD | 529 M USD |
| 2022 | 4.8 B USD | 729 M USD | 483 M USD |
| 2023 | 4.26 B USD | 113 M USD | -256 M USD |
| 2024e | 4.4 B USD | 276.81 M USD | 36.69 M USD |
| 2025e | 4.67 B USD | 492.37 M USD | 207.82 M USD |
| 2026e | 4.99 B USD | 617.66 M USD | 325.79 M USD |
| 2027e | 5.5 B USD | 1.02 B USD | 439.35 M USD |
| 2028e | 5.97 B USD | 1.2 B USD | 563.03 M USD |
| 2029e | 6.5 B USD | 0 USD | 708.86 M USD |
| 2030e | 7.1 B USD | 0 USD | 875 M USD |
Catalent stock margins US1488061029 · A112H2
The Catalent margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Catalent. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Catalent.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Catalent's sales revenue. A higher gross margin percentage indicates that the Catalent retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Catalent's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Catalent's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Catalent's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Catalent. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Catalent's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Catalent Margin History
| Catalent Gross margin | Catalent Profit margin | Catalent EBIT margin | Catalent Profit margin |
|---|---|---|---|
| 2030e | 24.4 % | 0 % | 12.32 % |
| 2029e | 24.4 % | 0 % | 10.91 % |
| 2028e | 24.4 % | 20.12 % | 9.43 % |
| 2027e | 24.4 % | 18.55 % | 7.99 % |
| 2026e | 24.4 % | 12.38 % | 6.53 % |
| 2025e | 24.4 % | 10.55 % | 4.45 % |
| 2024e | 24.4 % | 6.3 % | 0.83 % |
| 2023 | 24.4 % | 2.65 % | -6.01 % |
| 2022 | 33.61 % | 15.18 % | 10.06 % |
| 2021 | 33.82 % | 16.16 % | 13.23 % |
| 2020 | 31.78 % | 13.1 % | 5.59 % |
| 2019 | 31.97 % | 11.64 % | 5.46 % |
| 2018 | 30.55 % | 11.77 % | 3.39 % |
| 2017 | 31.54 % | 12.14 % | 5.29 % |
| 2016 | 31.79 % | 12.42 % | 6.03 % |
| 2015 | 33.61 % | 15.18 % | 11.59 % |
| 2014 | 32.75 % | 14.43 % | 0.89 % |
| 2013 | 31.58 % | 12.66 % | -2.76 % |
| 2012 | 32.96 % | 12.42 % | -1.44 % |
| 2011 | 32.78 % | 13.96 % | -3.53 % |
| 2010 | 29.78 % | 11.54 % | -19.56 % |
| 2009 | 27.22 % | 9.96 % | -22.03 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2009 | 27.22 % | 9.96 % | -22.03 % |
| 2010 | 29.78 % | 11.54 % | -19.56 % |
| 2011 | 32.78 % | 13.96 % | -3.53 % |
| 2012 | 32.96 % | 12.42 % | -1.44 % |
| 2013 | 31.58 % | 12.66 % | -2.76 % |
| 2014 | 32.75 % | 14.43 % | 0.89 % |
| 2015 | 33.61 % | 15.18 % | 11.59 % |
| 2016 | 31.79 % | 12.42 % | 6.03 % |
| 2017 | 31.54 % | 12.14 % | 5.29 % |
| 2018 | 30.55 % | 11.77 % | 3.39 % |
| 2019 | 31.97 % | 11.64 % | 5.46 % |
| 2020 | 31.78 % | 13.1 % | 5.59 % |
| 2021 | 33.82 % | 16.16 % | 13.23 % |
| 2022 | 33.61 % | 15.18 % | 10.06 % |
| 2023 | 24.4 % | 2.65 % | -6.01 % |
| 2024e | 24.4 % | 6.3 % | 0.83 % |
| 2025e | 24.4 % | 10.55 % | 4.45 % |
| 2026e | 24.4 % | 12.38 % | 6.53 % |
| 2027e | 24.4 % | 18.55 % | 7.99 % |
| 2028e | 24.4 % | 20.12 % | 9.43 % |
| 2029e | 24.4 % | 0 % | 10.91 % |
| 2030e | 24.4 % | 0 % | 12.32 % |
Catalent Aktienanalyse
What does Catalent do?
Catalent Inc is a global leader in advanced active ingredients and medical products, as well as solutions for drug development and manufacturing. The company was founded in 1933 by the Schering brothers in the USA and has become one of the preferred partners in the pharmaceutical industry due to its innovation, flexibility, and reliability. Catalent's business model is based on providing high-quality services and products that contribute to improving human health. The company offers a wide range of solutions, from active ingredient development to drug formulation and manufacturing, clinical trials, and product packaging. Through this comprehensive offering, Catalent helps its customers accelerate their drug development and product launch. The company is divided into different business sectors with specialized solutions, including the manufacturing of biopharmaceuticals such as antibodies, cell therapies, and vaccines, as well as medical devices, active ingredient manufacturing, and pharmaceutical development and manufacturing. Catalent's services also include active ingredient development, assisting customers in all stages of drug development from identifying new active ingredients to optimizing production processes. The company specializes in formulating drugs into suitable delivery forms that ensure safe and effective use, offering a variety of oral, inhalable, and parenteral formulations. Catalent also provides clinical trials, testing the efficacy and safety of drugs in clinical trials. The company has state-of-the-art facilities and expertise to professionally and successfully support its customers in conducting clinical studies. Additionally, Catalent offers a wide range of packaging solutions, including glass bottles, plastic containers, aluminum tubes, and the finishing and packaging of finished drugs. The company has advanced production systems that enable quick and flexible packaging production in any desired size and shape. Overall, Catalent provides its customers with a comprehensive range of services and products that enable fast and effective drug development and market launch. The company's strong innovation and diverse range of expertise make it a preferred partner in the pharmaceutical industry. Catalent ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Catalent's Profit Margins
The profit margins of Catalent represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Catalent's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Catalent's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Catalent's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Catalent’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Catalent stock
How has the profit developed compared to last year?
The profit has increased by -114.33% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Catalent publish its earnings?
Catalent publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Catalent?
The profits of Catalent are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Catalent?
You can learn more about the earnings of Catalent by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Catalent pay?
Over the past 12 months, Catalent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Catalent is expected to pay a dividend of 0 USD.
What is the dividend yield of Catalent?
The current dividend yield of Catalent is .
When does Catalent pay dividends?
Catalent pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Catalent?
Catalent paid dividends every year for the past 0 years.
What is the dividend of Catalent?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Catalent located?
Catalent is assigned to the 'Health' sector.
Wann musste ich die Aktien von Catalent kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Catalent from 7/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.
When did Catalent pay the last dividend?
The last dividend was paid out on 7/31/2024.
What was the dividend of Catalent in the year 2023?
In the year 2023, Catalent distributed 0 USD as dividends.
In which currency does Catalent pay out the dividend?
The dividends of Catalent are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Catalent stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Catalent
Our stock analysis for Catalent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Catalent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
